类风湿关节炎减停TNF抑制剂后影像学进展小幅增加的原因分析
基于DRESS研究18个月数据,比较减停TNF抑制剂与常规治疗组。减停组平均ΔSvdH为0.75单位、常规组为0.15单位,减停组32%患者ΔSvdH>0.5分、常规组15%。时间加权DAS28-CRP(尤其肿胀关节数)仅在减停组与影像学进展独立相关,提示减停过程中应尽量维持低疾病活动度并定期监测影像学进展。
要点
- 减停TNFi组平均ΔSvdH为0.75单位,常规治疗组为0.15单位。
- 减停组32%患者ΔSvdH>0.5分,常规组15%,两组差异均有统计学意义。
- 时间加权DAS28-CRP(尤其肿胀关节数)仅在减停组与影像学进展独立相关。
核心结论
- 影像学进展与更高的平均时间加权DAS28-CRP(尤其肿胀关节数)相关,但仅见于减停TNF抑制剂的患者。
- 该发现强调在减停TNF抑制剂的患者中应尽可能维持低疾病活动度,并定期检查影像学进展。
研究设计与样本
- 使用DRESS研究18个月数据,比较减停TNF抑制剂与常规治疗,共175/180例患者有18个月数据。
- 以ΔSvdH评分(线性回归)和ΔSvdH>0.5分患者比例(逻辑回归)为结局。
- 以短期和主要 flare 的累积发生率及每患者次数、平均时间加权DAS28-CRP和TNF抑制剂使用为自变量,按研究组分层回归并校正混杂因素。
主要发现
- 减停组平均ΔSvdH为0.75单位,常规治疗组为0.15单位(均p<0.05)。
- 减停组37/116例(32%)ΔSvdH>0.5分,常规治疗组9/59例(15%)(均p<0.05)。
- 平均时间加权DAS28-CRP与平均进展评分独立相关,但仅见于减停组;短期或主要 flare 的发生率或次数、TNF抑制剂使用均无独立关联。
- DAS28-CRP亚成分分析显示关联主要来自平均时间加权肿胀关节数。
- 未发现混杂因素。
临床怎么用
- 在减停TNF抑制剂的患者中,应尽可能维持低疾病活动度,尤其关注肿胀关节数的控制。
- 减停TNF抑制剂期间应定期检查影像学进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In a randomised controlled trial investigating tapering of TNF inhibitors (TNFi) compared with usual care (UC) in rheumatoid arthritis patients, minimal radiographic progression was more frequent in patients who attempted tapering. Possible explanations include higher incidence of flaring, higher mean disease activity or lower TNFi use. METHODS: 18 months data from the DRESS study were used. Change in Sharp-van der Heijde (ΔSvdH) score (linear regression) and proportion of patients with >0.5 ΔSvdH (logistic regression) were used as outcomes. The cumulative incidence and number of short-lived and major flares per patient, mean time-weighted disease activity (MTW-DAS28-CRP) and TNFi use were used as independent variables. Regression models were performed stratified per study group and corrected for possible confounders. RESULTS: 175 of 180 patients had 18-month data available. The mean ΔSvdH were 0.75 and 0.15 units with 37 of 116 (32%) and 9 of 59 (15%) patients exceeding 0.5 points in the tapering and UC group, respectively (both p<0.05). MTW-DAS28-CRP, but not incidence or number of short-lived or major flares, or TNFi use, was independently associated with the mean progression score, but only in the tapering group. Additional analyses on DAS28-CRP subcomponents showed that this was mainly caused by MTW swollen joint count. No confounders were identified. CONCLUSIONS: Radiographic progression was associated with higher MTW-DAS28-CRP (and especially swollen joint count), but only in patients who tapered TNFi. This finding stresses the importance of maintaining disease activity as low as possible in patients in whom TNFi is tapered and to check for radiographic progression regularly. TRIAL REGISTRATION NUMBER: NTR 3216; Post-results.
引用
- Bouman CA, den Broeder AA, van der Maas A, et al. What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors? RMD Open. 2017. PMID: 28405469. doi:10.1136/rmdopen-2016-000327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。